Breaking News: LLY – Market Insights, Analysis & Latest Updates

LLY
NVO

Analysis-Americans hungry for weight-loss drugs grapple with supply and insurance hurdles

Americans face ongoing challenges accessing Eli Lilly and Novo Nordisk's weight-loss drugs due to supply issues, insurance hurdles, and high costs, leading many to seek cheaper compounded alternatives.

investing.com • 04/11/2024 - 11:03 AM

Stocks to watch as White House race enters final stretch

The article discusses expectations around stock markets ahead of the U.S. presidential election, highlighting potential impacts from either Trump or Harris on various sectors and stocks.

investing.com • 01/11/2024 - 14:42 PM

LLY

Earnings call: Eli Lilly reports robust Q3 growth, raises 2024 guidance

Eli Lilly reported strong Q3 2024 earnings with 42% revenue growth driven by Mounjaro and Zepbound, raising its 2024 guidance amid optimism for ongoing expansion.

investing.com • 31/10/2024 - 11:28 AM

Alphabet, Biogen, Humana rise premarket; AMD, Eli Lilly fall

US stock futures rise slightly as earnings reports come in. Notable movers include Alphabet up 6.5% and AMD down 8%. Several companies reported mixed results.

investing.com • 30/10/2024 - 11:21 AM

LLY

Eli Lilly shares tumble as Q3 misses estimates, guidance lowered

Eli Lilly's shares fell 10% after Q3 earnings missed expectations; revenue grew 20% YoY, but the company lowered its 2024 forecasts for EPS and revenue.

investing.com • 30/10/2024 - 11:04 AM

LLY

Eli Lilly's weight-loss drug misses Wall Street expectations, shares tumble

Eli Lilly reported lower-than-expected Q3 profits and sales for its diabetes and weight-loss drugs, resulting in a significant share price drop due to increased costs and an acquisition charge.

investing.com • 30/10/2024 - 10:53 AM

Explainer-Who in the US benefits from $35 insulin?

Vice President Harris highlights insulin price cap achievements while advocacy groups point out ongoing costs and access issues for non-Medicare patients, urging broader regulatory changes.

investing.com • 30/10/2024 - 10:09 AM

Alphabet and AMD report, more earnings and GDP ahead - what's moving markets

US stock futures rise ahead of corporate earnings and economic data, with Alphabet's solid results contrasting AMD's disappointing forecast. Oil prices also gain as US inventories drop unexpectedly.

investing.com • 30/10/2024 - 08:43 AM

LLY
NVO

Eli Lilly’s weight-loss drug Mounjaro set for Hong Kong launch - report

Eli Lilly will launch weight-loss drug Mounjaro in Hong Kong, aiming for the wider China market, amid high demand and supply challenges for such medications.

investing.com • 28/10/2024 - 08:20 AM

LLY

Eli Lilly gets nod to launch weight-loss drug in Hong Kong - Bloomberg News

Eli Lilly plans to launch its weight-loss drug, tirzepatide, in Hong Kong by year-end, intensifying competition with Novo Nordisk in the growing $100 billion weight-loss market.

investing.com • 28/10/2024 - 01:06 AM

Currency